| lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients | |
| Zou, Hecun; Wu, Lan-Xiang; Yang, Yonglong; Li, Shuang; Mei, Ying; Liu, Yong-Bin; Zhang, Lihua; Cheng, Yu; Zhou, Hong-Hao* | |
| 刊名 | Oncotarget
 |
| 2017 | |
| 卷号 | 8期号:45页码:78767-78780 |
| 关键词 | HAR1A PVT1 diffuse glioma prognosis biomarker therapy outcome |
| ISSN号 | 1949-2553 |
| DOI | 10.18632/oncotarget.20226 |
| URL标识 | 查看原文 |
| WOS记录号 | WOS:000412111300048 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3340133 |
| 专题 | 中南大学 |
| 作者单位 | 1.[Zou, Hecun 2.Zhou, Hong-Hao 3.Wu, Lan-Xiang] Chongqing Med Univ, Inst Life Sci, Chongqing 400016, Peoples R China. |
| 推荐引用方式 GB/T 7714 | Zou, Hecun,Wu, Lan-Xiang,Yang, Yonglong,et al. lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients[J]. Oncotarget,2017,8(45):78767-78780. |
| APA | Zou, Hecun.,Wu, Lan-Xiang.,Yang, Yonglong.,Li, Shuang.,Mei, Ying.,...&Zhou, Hong-Hao*.(2017).lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients.Oncotarget,8(45),78767-78780. |
| MLA | Zou, Hecun,et al."lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients".Oncotarget 8.45(2017):78767-78780. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论